drugset / Trial / NCT00195780

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

NCT00195780

Phase 3 Completed 227 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the long-term safety profile of the Investigational Medication Depakote ER in the treatment of Bipolar I Disorder, manic or mixed episode, in children and adolescents ages 10-17.

Timeline

Start
2005-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule

Indications